Astrazeneca AZN
NYSE AZN
$156.91 -0.77 (-0.49%)
At close: Oct 2, 2026 · 4:00 PM EDT

Astrazeneca (AZN) Revenue (2009 - 2026)

Updated

Astrazeneca (AZN) reported Revenue of $15.38 billion for Q2 2026, up 6.4% from $14.46 billion a year earlier and up 0.6% from the prior quarter.

Analysis

Astrazeneca (AZN) Revenue (2009 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Astrazeneca's Revenue came in at $61.37 billion, up 8.6% year-over-year; for FY2025, it came in at $58.74 billion, up 8.6% from FY2024.

  • Revenue has increased for seven consecutive years, with a five-year compound annual growth rate of 17.2% (FY2020 to FY2025).
  • By year, Revenue came in at $54.07 billion in FY2024 (+18.0%), $45.81 billion in FY2023 (+3.3%), $44.35 billion in FY2022 (+18.5%) and $37.42 billion in FY2021 (+40.6%).
  • Five-year quarterly Revenue spans a low of $9.87 billion in Q3 2021 and a high of $15.5 billion in Q4 2025.
  • Year over year, Revenue has now increased in each of the last 13 quarters, with growth averaging 12.0% over the last eight quarters.
  • The high point for year-over-year Revenue in five years was Q4 2021 (growth of 62.1%); the low point was Q4 2022 (a decline of 6.7%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $15.29 billion (Q1 2026), $15.5 billion (Q4 2025) and $15.19 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 25.31 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 16.99 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 15.38 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 7.80 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 15.03 Bn
10 Vertex Pharmaceuticals 127.87 Bn 99.88 Bn 2.84 Bn 3.33 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.38 Bn
Mar 31, 2026 15.29 Bn
Dec 31, 2025 15.50 Bn
Sep 30, 2025 15.19 Bn
Jun 30, 2025 14.46 Bn
Mar 31, 2025 13.59 Bn
Dec 31, 2024 14.89 Bn
Sep 30, 2024 13.57 Bn
Jun 30, 2024 12.94 Bn
Mar 31, 2024 12.68 Bn
Dec 31, 2023 12.02 Bn
Sep 30, 2023 11.49 Bn
Jun 30, 2023 11.42 Bn
Mar 31, 2023 10.88 Bn
Dec 31, 2022 11.21 Bn
Sep 30, 2022 10.98 Bn
Jun 30, 2022 10.77 Bn
Mar 31, 2022 11.39 Bn
Dec 31, 2021 12.01 Bn
Sep 30, 2021 9.87 Bn
API Access

Astrazeneca Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=AZN&period=max&api_key=YOUR_API_KEY